Moolec Science SA MLEC.OQ MLEC.O is expected to show a fall in quarterly revenue when it reports results on December 12 (estimated) for the period ending September 30 2024
The Luxembourg Luxembourg-based company is expected to report a 24.8% decrease in revenue to $1.309 million from $1.74 million a year ago, according to the estimate from one analyst, based on LSEG data.
LSEG's mean analyst estimate for Moolec Science SA is for a loss of 7 cents per share.
The one available analyst rating on the shares is "buy".
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Moolec Science SA is $3.00, above its last closing price of $0.86.
This summary was machine generated December 10 at 13:33 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Comments